The therapy targets the LRRC15 protein and is designed for enhanced tumor penetration and differentiated anti-tumor activity in solid tumors with the highest unmet needs.
The drug is designed to improve functional capacity and reduce symptoms by inhibiting cardiac myosin motor activity
Additional investments planned to expand the site’s capacity and capabilities to support growing manufacturing programs
The therapy also drove additional weight loss at the higher 1.8 mg dose without plateauing and maintained a favorable tolerability profile
The system is intended for some of the tiniest patients—premature infants weighing as little as two pounds
Emcure becomes the first Indian company to exclusively distribute and commercialise Poviztra, a second brand of Novo Nordisk’s Semaglutide injection for weight management
The announcement came during the inauguration of the college’s Innovation & Incubation Centre and Health Club
The pharma company will donate more than seven tons of its active pharmaceutical ingredient (API) to bolster the American supply chain
Takeda said zasocitinib was generally well tolerated, with a safety profile consistent with earlier studies
Subscribe To Our Newsletter & Stay Updated
